Total medical devices industry artificial intelligence deals worth $590.1m were announced globally for July 2021, with the $250m private equity deal with Certara USA being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 50.4% over the previous month of $1.19bn and a drop of 71.1% when compared with the last 12-month average of $2.04bn.
In terms of number of artificial intelligence deals, the sector saw a rise of 21.05% with 23 deals in July 2021 when compared to the last 12-month average of 19 deals.
In value terms, North America led the activity with artificial intelligence deals worth $298.35m in July 2021.
medical devices industry artificial intelligence deals in July 2021: Top deals
The top five artificial intelligence deals accounted for 86.3% of the overall value during July 2021.
The combined value of the top five artificial intelligence deals stood at $509.2m, against the overall value of $590.1m recorded for the month.
The top five medical devices industry artificial intelligence deals of July 2021 tracked by GlobalData were:
2) The $139.1m venture financing of Beijing Infervision Technology by CCB Trust,Chinese Fund of Funds (FOF),Goldman Sachs Asset Management,Springhill Fund,TopoScend Capital and Zhongguancun M&A Fund
3) Aidoc $66m venture financing deal with General Catalyst Partners
5) ScreenPoint Medical $28m venture financing deal with Insight Partners,Oost,Siemens Healthineers and University Radiology Group PC
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.